Advertisement
Screener

USANA HEALTH SCIENCES, INC. (USNA) Fair Value of Assets Acquired

1.5 / 5 stars · 32/110 Roast Me

USANA HEALTH SCIENCES, INC. Fair Value of Assets Acquired

USANA HEALTH SCIENCES, INC. (USNA) reported Fair Value of Assets Acquired of $613.00 thousand for the 6-month period ending 2020-06-27, per its 10-Q filed 2020-08-04.

Discontinued › Cash Flow › Other Cash Flow Items

us-gaap:FairValueOfAssetsAcquired · last filed 2020-08-04

  • USANA HEALTH SCIENCES, INC. fair value of assets acquired for the quarter ending 2020-06-27 was $5.00K, a 98.77% decline year-over-year.
  • USANA HEALTH SCIENCES, INC. fair value of assets acquired for the quarter ending 2020-03-28 was $608.00K, a 142.23% increase year-over-year.
  • USANA HEALTH SCIENCES, INC. fair value of assets acquired for the quarter ending 2019-12-28 was $775.00K, a 434.48% increase year-over-year.
  • USANA HEALTH SCIENCES, INC. fair value of assets acquired for the quarter ending 2019-09-28 was -$436.00K.
  • USANA HEALTH SCIENCES, INC. fair value of assets acquired for fiscal 2019 was $998.00K, a 411.79% increase from fiscal 2018.
  • USANA HEALTH SCIENCES, INC. fair value of assets acquired for fiscal 2018 was $195.00K, a 78.90% increase from fiscal 2017.
  • USANA HEALTH SCIENCES, INC. fair value of assets acquired for fiscal 2017 was $109.00K, a 95.08% decline from fiscal 2016.
  • USANA HEALTH SCIENCES, INC. fair value of assets acquired for fiscal 2016 was $2.22M, a 67.71% decline from fiscal 2016.
Period endFair Value of Assets Acquired 3 monthFair Value of Assets Acquired 6 monthFair Value of Assets Acquired 9 monthFair Value of Assets Acquired 12 month
2020-06-27$5.00K
derived: 10-Q 6 month − 10-Q 3 month · filed 2020-08-04
$613.00K
10-Q · filed 2020-08-04
$1.39M
derived: sum of 3 quarters · filed 2020-08-04
$952.00K
derived: sum of 4 quarters · filed 2020-08-04
2020-03-28$608.00K
10-Q · filed 2020-05-05
$1.38M
derived: sum of 2 quarters · filed 2020-05-05
$947.00K
derived: sum of 3 quarters · filed 2020-05-05
$1.35M
derived: sum of 4 quarters · filed 2020-08-04
2019-12-28$775.00K
derived: 10-K 12 month − 10-Q 9 month · filed 2020-02-25
$339.00K
derived: sum of 2 quarters · filed 2020-02-25
$747.00K
derived: sum of 3 quarters · filed 2020-08-04
$998.00K
10-K · filed 2020-02-25
2019-09-28-$436.00K
derived: 10-Q 9 month − 10-Q 6 month · filed 2019-11-05
-$28.00K
derived: sum of 2 quarters · filed 2020-08-04
$223.00K
10-Q · filed 2019-11-05
$368.00K
derived: sum of 4 quarters · filed 2020-08-04
2019-06-29$408.00K
derived: 10-Q 6 month − 10-Q 3 month · filed 2020-08-04
$659.00K
10-Q · filed 2020-08-04
$804.00K
derived: sum of 3 quarters · filed 2020-08-04
$703.00K
derived: sum of 4 quarters · filed 2020-08-04
2019-03-30$251.00K
10-Q · filed 2020-05-05
$396.00K
derived: sum of 2 quarters · filed 2020-05-05
$295.00K
derived: sum of 3 quarters · filed 2020-05-05
$287.00K
derived: sum of 4 quarters · filed 2020-05-05
2018-12-29$145.00K
derived: 10-K 12 month − 10-Q 9 month · filed 2020-02-25
$44.00K
derived: sum of 2 quarters · filed 2020-02-25
$36.00K
derived: sum of 3 quarters · filed 2020-02-25
$195.00K
10-K · filed 2020-02-25
2018-09-29-$101.00K
derived: 10-Q 9 month − 10-Q 6 month · filed 2019-11-05
-$109.00K
derived: sum of 2 quarters · filed 2019-11-05
$50.00K
10-Q · filed 2019-11-05
-$43.00K
derived: sum of 4 quarters · filed 2020-02-25
2018-06-30-$8.00K
derived: 10-Q 6 month − 10-Q 3 month · filed 2019-08-06
$151.00K
10-Q · filed 2019-08-06
$58.00K
derived: sum of 3 quarters · filed 2020-02-25
$235.00K
derived: sum of 4 quarters · filed 2020-02-25
2018-03-31$159.00K
10-Q · filed 2019-05-07
$66.00K
derived: sum of 2 quarters · filed 2020-02-25
$243.00K
derived: sum of 3 quarters · filed 2020-02-25
2017-12-30-$93.00K
derived: 10-K 12 month − 10-Q 9 month · filed 2020-02-25
$84.00K
derived: sum of 2 quarters · filed 2020-02-25
$109.00K
10-K · filed 2020-02-25
2017-09-30$177.00K
derived: 10-Q 9 month − 10-Q 6 month · filed 2018-11-07
$202.00K
10-Q · filed 2018-11-07
2017-07-01$25.00K
10-Q · filed 2018-08-08
2016-12-31$453.00K
derived: 10-K 12 month − 10-Q 9 month · filed 2019-02-26
-$117.00K
derived: sum of 2 quarters · filed 2019-02-26
-$439.00K
derived: sum of 3 quarters · filed 2019-02-26
$2.22M
10-K · filed 2019-02-26
2016-10-01-$570.00K
derived: 10-Q 9 month − 10-Q 6 month · filed 2017-11-08
-$892.00K
derived: sum of 2 quarters · filed 2017-11-08
$1.76M
10-Q · filed 2017-11-08
$6.72M
derived: sum of 4 quarters · filed 2018-02-28
2016-07-02-$322.00K
derived: 10-Q 6 month − 10-Q 3 month · filed 2017-08-09
$2.33M
10-Q · filed 2017-08-09
$7.29M
derived: sum of 3 quarters · filed 2018-02-28
$9.05M
derived: sum of 4 quarters · filed 2018-02-28
2016-04-02$2.65M
10-Q · filed 2017-05-10
$7.61M
derived: sum of 2 quarters · filed 2018-02-28
$9.37M
derived: sum of 3 quarters · filed 2018-02-28
$8.61M
derived: sum of 4 quarters · filed 2018-02-28
2016-01-02$4.96M
derived: 10-K 12 month − 10-Q 9 month · filed 2018-02-28
$6.71M
derived: sum of 2 quarters · filed 2018-02-28
$5.95M
derived: sum of 3 quarters · filed 2018-02-28
$6.86M
10-K · filed 2018-02-28
2015-10-03$1.76M
derived: 10-Q 9 month − 10-Q 6 month · filed 2016-11-09
$996.00K
derived: sum of 2 quarters · filed 2016-11-09
$1.91M
10-Q · filed 2016-11-09
2015-07-04-$761.00K
derived: 10-Q 6 month − 10-Q 3 month · filed 2016-08-09
$149.00K
10-Q · filed 2016-08-09
2015-04-04$910.00K
10-Q · filed 2016-05-11
2015-01-03$1.80M
10-K · filed 2017-03-01
2014-06-28$331.00K
10-Q · filed 2015-08-12

Similar stocks

Stock NameCountryMarket CapPE Ratio
Niagen Bioscience, Inc. (NAGE)United States$0.238B15.72
Canopy Growth Corp (CGC)$0.395B
FITLIFE BRANDS, INC. (FTLF)United States$0.087B16.59
MANNATECH INC (MTEX)United States$0.014B
NATURAL ALTERNATIVES INTERNATIONAL INC (NAII)United States$0.011B-1.16
Synergy CHC Corp. (SNYR)United States$0.001B
Functional Brands Inc. (MEHA)United States$0.001B
Tilray Brands, Inc. (TLRY)United States$0.554B-5.97
Cronos Group Inc. (CRON)$1.223B
Definium Therapeutics, Inc. (DFTX)United States$4.931B-17.87